Advertisement
Women are less likely than men to fill a prescription for high-intensity statins after hospitalization for myocardial infarction

Women Less Likely to Fill Post-MI Statin Prescription

0
56 percent of men, 47 percent of women filled high-intensity statin after myocardial infarction
For metastatic non-small-cell lung cancer (NSCLC)

Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC

0
And, nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden
Costs associated with treating antibiotic-resistant infections have doubled since 2002

It Costs $2.2 Billion a Year to Treat Antibiotic Resistance

0
Antibiotic resistance adds $1,383 to the cost of treating a bacterial infection
For adults with type 1 diabetes with suboptimal control despite using multiple insulin injections

Continuous Glucose Monitoring Cost-Effective in T1DM

0
CGM reduces HbA1c, hypoglycemia events for patients with suboptimal control compared to control
Supplementation with n-3 fatty acids is not associated with significant benefit in dry eye disease

n-3 Fatty Acids Don’t Seem to Be of Any Benefit in Dry Eye Disease

0
Patients randomized to n-3 supplementation did not have significantly better outcomes versus placebo
The U.S. Food and Drug Administration announced Friday that it has issued tough new restrictions on the sale of dietary supplements that contain dangerously high amounts of caffeine.

FDA Cracks Down on Caffeine-Loaded Dietary Supplements

0
Products have been linked to at least two deaths in otherwise healthy people
For patients with breast cancer

Endocrine Therapy-Induced Alopecia Seen in Breast Cancer

0
92 percent had grade 1 severity alopecia with endocrine tx; pattern similar to androgenetic alopecia
Pharmacist use of telemedicine is a promising vehicle for improving patient management of diabetes

Pharmacists Can Help With DM Management Via Telemedicine

0
Telemedicine could provide real-time feedback loop and allow pharmacists to help patients self-manage
Physicians receiving general payments from pharmaceutical companies are more likely to prescribe their drugs

Odds of Prescribing Drugs Up With Doc Receipt of Payments

0
Doctors who receive general payment for cancer drug more likely to prescribe drug marketed by company
Gemcitabine and cisplatin plus ipilimumab is associated with a 69 percent objective response rate and 61 percent one-year overall survival for patients with metastatic urothelial cancer

Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer

0
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab